{
  "DOI": "10.1007/s10689-009-9242-z",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-009-9242-z",
  "alternative-id": [
    "9242"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Morgan",
      "given": "Debra",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Sylvester",
      "given": "Heather",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lucas",
      "given": "F. Lee",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Miesfeldt",
      "given": "Susan",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2009,
        4,
        3
      ]
    ],
    "date-time": "2009-04-03T14:14:41Z",
    "timestamp": 1238768081000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:45:59Z",
    "timestamp": 1559252759000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        15
      ]
    ],
    "date-time": "2023-09-15T23:39:17Z",
    "timestamp": 1694821157631
  },
  "is-referenced-by-count": 29,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2009,
        4,
        4
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2009,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2009,
            4,
            4
          ]
        ],
        "date-time": "2009-04-04T00:00:00Z",
        "timestamp": 1238803200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-009-9242-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-009-9242-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-009-9242-z",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "277-287",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2009,
        4,
        4
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2009,
        4,
        4
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2009,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1200/JCO.2003.05.096",
      "author": "HT Lynch",
      "doi-asserted-by": "crossref",
      "first-page": "740",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR1",
      "unstructured": "Lynch HT, Snyder CL et al (2003) Hereditary breast ovarian cancer at the bedside: role of the medical oncologist. J Clin Oncol 21(4):740–753. doi: 10.1200/JCO.2003.05.096",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nrc1431",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "665",
      "issue": "9",
      "journal-title": "Nat Rev Cancer",
      "key": "9242_CR2",
      "unstructured": "Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665–676. doi: 10.1038/nrc1431",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "676",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "9242_CR3",
      "unstructured": "Ford D, Easton DF et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676–689. doi: 10.1086/301749",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "9242_CR4",
      "unstructured": "Antoniou A, Pharoah PD et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130. doi: 10.1086/375033",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1086/513891",
      "author": "DF Easton",
      "doi-asserted-by": "crossref",
      "first-page": "120",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "9242_CR5",
      "unstructured": "Easton DF, Steele L et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12–13. Am J Hum Genet 61(1):120–128. doi: 10.1086/513891",
      "volume": "61",
      "year": "1997"
    },
    {
      "DOI": "10.1056/NEJM199705153362001",
      "author": "JP Struewing",
      "doi-asserted-by": "crossref",
      "first-page": "1401",
      "issue": "20",
      "journal-title": "N Engl J Med",
      "key": "9242_CR6",
      "unstructured": "Struewing JP, Hartge P et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401–1408. doi: 10.1056/NEJM199705153362001",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1093/jnci/91.15.1310",
      "author": "The Breast Cancer Linkage Consortium",
      "doi-asserted-by": "crossref",
      "first-page": "1310",
      "issue": "15",
      "journal-title": "J Natl Cancer Inst",
      "key": "9242_CR7",
      "unstructured": "The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310–1316. doi: 10.1093/jnci/91.15.1310",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1093/jnci/94.18.1365",
      "author": "MS Brose",
      "doi-asserted-by": "crossref",
      "first-page": "1365",
      "issue": "18",
      "journal-title": "J Natl Cancer Inst",
      "key": "9242_CR8",
      "unstructured": "Brose MS, Rebbeck TR et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94(18):1365–1372",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/94.18.1358",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "1358",
      "issue": "18",
      "journal-title": "J Natl Cancer Inst",
      "key": "9242_CR9",
      "unstructured": "Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94(18):1358–1365",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2006.09.1066",
      "author": "S Chen",
      "doi-asserted-by": "crossref",
      "first-page": "1329",
      "issue": "11",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR10",
      "unstructured": "Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329–1333. doi: 10.1200/JCO.2006.09.1066",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.7326/0003-4819-143-5-200509060-00011",
      "author": "U.S. Preventive Services Task Force",
      "doi-asserted-by": "crossref",
      "first-page": "355",
      "issue": "5",
      "journal-title": "Ann Intern Med",
      "key": "9242_CR11",
      "unstructured": "U.S. Preventive Services Task Force (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 143(5):355–361",
      "volume": "143",
      "year": "2005"
    },
    {
      "DOI": "10.1200/JCO.2007.13.9626",
      "author": "ND Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "1331",
      "issue": "8",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR12",
      "unstructured": "Kauff ND, Domchek SM et al (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331–1337. doi: 10.1200/JCO.2007.13.9626",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2005.10.080",
      "author": "LJ Herrinton",
      "doi-asserted-by": "crossref",
      "first-page": "4275",
      "issue": "19",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR13",
      "unstructured": "Herrinton LJ, Barlow WE et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23(19):4275–4286. doi: 10.1200/JCO.2005.10.080",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S1470-2045(06)70585-X",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "223",
      "issue": "3",
      "journal-title": "Lancet Oncol",
      "key": "9242_CR14",
      "unstructured": "Domchek SM, Friebel TM et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223–229. doi: 10.1016/S1470-2045(06)70585-X",
      "volume": "7",
      "year": "2006"
    },
    {
      "DOI": "10.1002/ijc.21536",
      "author": "J Gronwald",
      "doi-asserted-by": "crossref",
      "first-page": "2281",
      "issue": "9",
      "journal-title": "Int J Cancer",
      "key": "9242_CR15",
      "unstructured": "Gronwald J, Tung N et al (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118(9):2281–2284. doi: 10.1002/ijc.21536",
      "volume": "118",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2005.00.133",
      "author": "M Epplein",
      "doi-asserted-by": "crossref",
      "first-page": "4713",
      "issue": "21",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR16",
      "unstructured": "Epplein M, Koon KP et al (2005) Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. J Clin Oncol 23(21):4713–4718. doi: 10.1200/JCO.2005.00.133",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1207/S15430154JCE1802_11",
      "author": "LC Friedman",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "issue": "2",
      "journal-title": "J Cancer Educ",
      "key": "9242_CR17",
      "unstructured": "Friedman LC, Cooper HP et al (2003) Primary care physicians’ attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results. J Cancer Educ 18(2):91–94. doi: 10.1207/S15430154JCE1802_11",
      "volume": "18",
      "year": "2003"
    },
    {
      "author": "L Wideroff",
      "first-page": "295",
      "issue": "4",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9242_CR18",
      "unstructured": "Wideroff L, Freedman AN et al (2003) Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev 12(4):295–303",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ajmg.a.20431",
      "author": "ST Tinley",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "issue": "1",
      "journal-title": "Am J Med Genet",
      "key": "9242_CR19",
      "unstructured": "Tinley ST, Houfek J et al (2004) Screening adherence in BRCA1/2 families is associated with primary physicians’ behavior. Am J Med Genet 125(1):5–11. doi: 10.1002/ajmg.a.20431",
      "volume": "125",
      "year": "2004"
    },
    {
      "DOI": "10.1006/pmed.2000.0684",
      "author": "C Lerman",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "issue": "1",
      "journal-title": "Prev Med",
      "key": "9242_CR20",
      "unstructured": "Lerman C, Hughes C et al (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31(1):75–80. doi: 10.1006/pmed.2000.0684",
      "volume": "31",
      "year": "2000"
    },
    {
      "DOI": "10.1002/ajmg.a.10102",
      "author": "JR Botkin",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "issue": "3",
      "journal-title": "Am J Med Genet",
      "key": "9242_CR21",
      "unstructured": "Botkin JR, Smith KR et al (2003) Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet 118(3):201–209. doi: 10.1002/ajmg.a.10102",
      "volume": "118",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2003.09.052",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "crossref",
      "first-page": "1675",
      "issue": "9",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR22",
      "unstructured": "Meijers-Heijboer H, Brekelmans CT et al (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21(9):1675–1681. doi: 10.1200/JCO.2003.09.052",
      "volume": "21",
      "year": "2003"
    },
    {
      "author": "BN Peshkin",
      "first-page": "1115",
      "issue": "10 Pt 1",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9242_CR23",
      "unstructured": "Peshkin BN, Schwartz MD et al (2002) Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1115–1118",
      "volume": "11",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2002.20.5.1260",
      "author": "L Scheuer",
      "doi-asserted-by": "crossref",
      "first-page": "1260",
      "issue": "5",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR24",
      "unstructured": "Scheuer L, Kauff N et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20(5):1260–1268. doi: 10.1200/JCO.20.5.1260",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1023/A:1013800409238",
      "author": "C Isaacs",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9242_CR25",
      "unstructured": "Isaacs C, Peshkin BN et al (2002) Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 71(2):103–112. doi: 10.1023/A:1013800409238",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2007.12.6078",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "1093",
      "issue": "7",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR26",
      "unstructured": "Metcalfe KA, Jan Lubinski J et al (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the hereditary breast cancer clinical study group. J Clin Oncol 26(7):1093–1097. doi: 10.1200/JCO.2007.12.6078",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2005.02.2368",
      "author": "CH Barcenas",
      "doi-asserted-by": "crossref",
      "first-page": "354",
      "issue": "3",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR27",
      "unstructured": "Barcenas CH, Hosain GM et al (2006) Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24(3):354–360. doi: 10.1200/JCO.2005.02.2368",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2005.01.9737",
      "author": "PA James",
      "doi-asserted-by": "crossref",
      "first-page": "707",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9242_CR28",
      "unstructured": "James PA, Doherty R et al (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24(4):707–715. doi: 10.1200/JCO.2005.01.9737",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1001/jama.1997.03540360065034",
      "author": "W Burke",
      "doi-asserted-by": "crossref",
      "first-page": "997",
      "issue": "12",
      "journal-title": "JAMA",
      "key": "9242_CR29",
      "unstructured": "Burke W, Daly M, Garber J et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277(12):997–1003. doi: 10.1001/jama.277.12.997",
      "volume": "277",
      "year": "1997"
    },
    {
      "key": "9242_CR30",
      "unstructured": "NCCN Breast Cancer Panel (2000) NCCN practice guidelines for genetics/familial high-risk screening. Breast, Version 1"
    },
    {
      "DOI": "10.1002/ajmg.a.20431",
      "author": "S Tinley",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "issue": "1",
      "journal-title": "Am J Med Genet",
      "key": "9242_CR31",
      "unstructured": "Tinley S et al (2004) Screening adherence in BRCA 1/2 families is associated with primary physicians’ behavior. Am J Med Genet 125A(1):5–11. doi: 10.1002/ajmg.a.20431",
      "volume": "125A",
      "year": "2004"
    },
    {
      "DOI": "10.1056/NEJMra012284",
      "author": "R Wooster",
      "doi-asserted-by": "crossref",
      "first-page": "2339",
      "issue": "23",
      "journal-title": "N Engl J Med",
      "key": "9242_CR32",
      "unstructured": "Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348(23):2339–2347. doi: 10.1056/NEJMra012284",
      "volume": "348",
      "year": "2003"
    },
    {
      "DOI": "10.1097/01.GIM.0000151155.36470.FF",
      "author": "MR McClain",
      "doi-asserted-by": "crossref",
      "first-page": "28",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "9242_CR33",
      "unstructured": "McClain MR, Palomaki GE et al (2005) Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications. Genet Med 7(1):28–33. doi: 10.1097/01.GIM.0000151155.36470.FF",
      "volume": "7",
      "year": "2005"
    },
    {
      "DOI": "10.1001/jama.1996.03530480027036",
      "author": "C Lerman",
      "doi-asserted-by": "crossref",
      "first-page": "1885",
      "issue": "24",
      "journal-title": "JAMA",
      "key": "9242_CR34",
      "unstructured": "Lerman C, Narod S et al (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 275(24):1885–1892. doi: 10.1001/jama.275.24.1885",
      "volume": "275",
      "year": "1996"
    },
    {
      "DOI": "10.1093/jnci/93.21.1633",
      "author": "LC Hartmann",
      "doi-asserted-by": "crossref",
      "first-page": "1633",
      "issue": "21",
      "journal-title": "J Natl Cancer Inst",
      "key": "9242_CR35",
      "unstructured": "Hartmann LC, Sellers TA et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637",
      "volume": "93",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJMoa020119",
      "author": "ND Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "1609",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "9242_CR36",
      "unstructured": "Kauff ND, Satagopan JM et al (2002) Risk-reducing salpingooophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609–1615. doi: 10.1056/NEJMoa020119",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1001/jama.286.18.2251",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "2251",
      "issue": "18",
      "journal-title": "JAMA",
      "key": "9242_CR37",
      "unstructured": "King MC, Wieand S et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 286(18):2251–2256. doi: 10.1001/jama.286.18.2251",
      "volume": "286",
      "year": "2001"
    },
    {
      "DOI": "10.1001/archinte.166.20.2260",
      "author": "K Armstrong",
      "doi-asserted-by": "crossref",
      "first-page": "2260",
      "issue": "20",
      "journal-title": "Arch Intern Med",
      "key": "9242_CR38",
      "unstructured": "Armstrong K, Quistberg DA et al (2006) Prescription of tamoxifen for breast cancer prevention by primary care physicians. Arch Intern Med 166(20):2260–2265. doi: 10.1001/archinte.166.20.2260",
      "volume": "166",
      "year": "2006"
    },
    {
      "DOI": "10.1370/afm.284",
      "author": "R Taylor",
      "doi-asserted-by": "crossref",
      "first-page": "242",
      "issue": "3",
      "journal-title": "Ann Fam Med",
      "key": "9242_CR39",
      "unstructured": "Taylor R, Taguchi K (2005) Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump. Ann Fam Med 3(3):242–247. doi: 10.1370/afm.284",
      "volume": "3",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/93.14.1095",
      "author": "MJ Stoutjesdijk",
      "doi-asserted-by": "crossref",
      "first-page": "1095",
      "issue": "14",
      "journal-title": "J Natl Cancer Inst",
      "key": "9242_CR40",
      "unstructured": "Stoutjesdijk MJ, Boetes C et al (2001) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93(14):1095–1102. doi: 10.1093/jnci/93.14.1095",
      "volume": "93",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJMoa031759",
      "author": "M Kriege",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "issue": "5",
      "journal-title": "N Engl J Med",
      "key": "9242_CR41",
      "unstructured": "Kriege M, Brekelman CT et al (2004) Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427–437. doi: 10.1056/NEJMoa031759",
      "volume": "351",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0140-6736(05)66481-1",
      "author": "MO Leach",
      "doi-asserted-by": "crossref",
      "first-page": "1769",
      "issue": "9473",
      "journal-title": "Lancet",
      "key": "9242_CR42",
      "unstructured": "Leach MO, Boggis CR et al (2005) Screening with magnetic resonance imaging and mammography in a UK population at high familial risk of breast cancer : a prospective multicentre cohort study (MARIBS). Lancet 365(9473):1769–1778. doi: 10.1016/S0140-6736(05)66481-1",
      "volume": "365",
      "year": "2005"
    },
    {
      "DOI": "10.1001/jama.292.11.1317",
      "author": "E Warner",
      "doi-asserted-by": "crossref",
      "first-page": "1317",
      "journal-title": "JAMA",
      "key": "9242_CR43",
      "unstructured": "Warner E, Plewes DB et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317–1325. doi: 10.1001/jama.292.11.1317",
      "volume": "292",
      "year": "2004"
    },
    {
      "DOI": "10.3322/canjclin.57.2.75",
      "author": "D Saslow",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "journal-title": "CA Cancer J Clin",
      "key": "9242_CR44",
      "unstructured": "Saslow D et al (2007) American cancer society guidelines breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89",
      "volume": "57",
      "year": "2007"
    }
  ],
  "reference-count": 44,
  "references-count": 44,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-009-9242-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting"
  ],
  "type": "journal-article",
  "volume": "8"
}